Detail
LncRNA Name | SNHG16 |
Synonyms | SNHG16, Nbla10727, Nbla12061, ncRAN |
Region | GRCh38_17:76557766-76565348 Sequence |
Ensembl | ENSG00000163597 |
RefSeq | NR_038108 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✘ |
MiRNA | ✔ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | esophageal squamous cell cancer |
ICD-0-3 | |
Methods | qPCR, Luciferase reporter assay, Western blot, RIP |
Sample | esophageal squamous cell carcinoma tissues, cell lines (eca109, EC9706, TE1, Kyse-30 and Kyse-70) |
Expression Pattern | differential expression |
Function Description | miR-140-5p could interact with SNHG16 and the level of miR-140-5p was inverse correlated with SNHG16 in ESCC specimens.SNHG16 directly targets miR-140-5p by binding with microRNA binding site harboring in the SNHG16 sequence. SNHG16 could act as an oncogenic lncRNA that promotes tumor progression through acting as an endogenous 'sponge' by competing with miR-140-5p, thereby regulating target ZEB1. |
Pubmed ID | 29416674 |
Year | 2017 |
Title | SNHG16/miR-140-5p axis promotes esophagus cancer cell proliferation, migration and EMT formation through regulating ZEB1. |
External Links |
Links for SNHG16 | GenBank HGNC lncrnadb Noncode |
Links for esophageal squamous cell cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.